For research use only. Not for therapeutic Use.
Rimantadine-d4 hydrochloride (CAS: 350818-67-6), a premium pharmaceutical research compound designed for advanced antiviral studies. As a deuterated analog of Rimantadine, it offers enhanced stability and improved pharmacokinetic properties. Rimantadine-d4 hydrochloride is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel antiviral therapies. Trusted by leading laboratories, Rimantadine-d4 hydrochloride is your go-to solution for cutting-edge antiviral research. Unlock new possibilities in antiviral treatment with Rimantadine-d4 hydrochloride, where innovation meets reliability.
Catalog Number | S000250 |
CAS Number | 350818-67-6 |
Molecular Formula | C12H18D4ClN |
Purity | ≥95% |
Target | Influenza Virus |
IUPAC Name | 1-(1-adamantyl)-1,2,2,2-tetradeuterioethanamine;hydrochloride |
InChI | InChI=1S/C12H21N.ClH/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12;/h8-11H,2-7,13H2,1H3;1H/i1D3,8D; |
InChIKey | OZBDFBJXRJWNAV-VQQQFJCBSA-N |
SMILES | [2H]C([2H])([2H])C([2H])(C12CC3CC(C1)CC(C3)C2)N.Cl |
Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Tominack, R.L. and F.G. Hayden, Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am, 1987. 1(2): p. 459-78. [3]. Hall, C.B., et al., Children with influenza A infection: treatment with rimantadine. Pediatrics, 1987. 80(2): p. 275-82. |